ENTRY       D00503                      Drug
NAME        Perphenazine (JP18/USP/INN);
            Trilafon (TN)
PRODUCT
  GENERIC   PERPHENAZINE (Actavis Pharma)
            PERPHENAZINE (American Health Packaging)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (Bryant Ranch Prepack)
            PERPHENAZINE (DOH CENTRAL PHARMACY)
            PERPHENAZINE (Golden State Medical Supply)
            PERPHENAZINE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            PERPHENAZINE (Major Pharmaceuticals)
            PERPHENAZINE (Par Pharmaceutical)
            PERPHENAZINE (Proficient Rx LP)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (REMEDYREPACK)
            PERPHENAZINE (Rising Pharmaceuticals)
            PERPHENAZINE (Sandoz)
            PERPHENAZINE (Wilshire Pharmaceuticals)
            PERPHENAZINE (Zydus Lifesciences Limited)
            PERPHENAZINE (Zydus Pharmaceuticals (USA))
FORMULA     C21H26ClN3OS
EXACT_MASS  403.1485
MOL_WEIGHT  403.9686
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG03200  Antipsychotic agent
              DG01905  Phenothiazine antipsychotics
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Same as: C07427
            Therapeutic category: 1172
            ATC code: N05AB03
            Chemical structure group: DG00875
            Product (DG00875): D00503<JP/US> D02037<JP> D04038<JP> D04965<JP>
            Product (mixture): D10294<US>
EFFICACY    Antipsychotic, Dopamine D2 receptor antagonist
  DISEASE   Schizophrenia [DS:H01649]
COMMENT     Phenothiazine derivative
TARGET      DRD2 [HSA:1813] [KO:K04145]
  PATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07029  Antipsychotics - phenothiazines
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AB Phenothiazines with piperazine structure
                 N05AB03 Perphenazine
                  D00503  Perphenazine (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiemetics
              Antiemetics, Other
               Perphenazine
                D00503  Perphenazine (JP18/USP/INN)
             Antipsychotics
              1st Generation/Typical
               Perphenazine
                D00503  Perphenazine (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1172  Phenothiazines
                 D00503  Perphenazine (JP18/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00875  Perphenazine
                 D00503  Perphenazine
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00875  Perphenazine
                 D00503  Perphenazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00875  Perphenazine
                D00503  Perphenazine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D00503  Perphenazine (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00503  Perphenazine
              D00503  Perphenazine tablets
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00503
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00503
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00875  Perphenazine
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00875  Perphenazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00875  Perphenazine
DBLINKS     CAS: 58-39-9
            PubChem: 7847569
            ChEBI: 8028
            LigandBox: D00503
            NIKKAJI: J1.387K
ATOM        27
            1   C8x C    16.1000  -11.4100
            2   C8x C    16.1000  -12.8100
            3   C8x C    17.3124  -13.5100
            4   C8y C    18.5249  -12.8100
            5   C8y C    18.5249  -11.4100
            6   C8x C    17.3124  -10.7100
            7   S2x S    19.7373  -13.5100
            8   C8y C    20.9497  -12.8100
            9   C8y C    20.9497  -11.4100
            10  N4y N    19.7373  -10.7100
            11  C8x C    22.1622  -13.5100
            12  C8x C    23.3746  -12.8100
            13  C8y C    23.3746  -11.4100
            14  C8x C    22.1622  -10.7100
            15  C1b C    19.7373   -9.3100
            16  C1b C    20.9518   -8.6088
            17  C1b C    22.1483   -9.2998
            18  N1y N    23.3351   -8.6146
            19  C1x C    24.5266   -9.3028
            20  C1x C    25.7391   -8.6029
            21  N1y N    25.7393   -7.2029
            22  C1x C    24.5478   -6.5148
            23  C1x C    23.3353   -7.2146
            24  C1b C    26.9641   -6.4958
            25  C1b C    28.1720   -7.1932
            26  O1a O    29.3532   -6.5113
            27  X   Cl   24.5911  -10.7077
BOND        30
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    8  11 2
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16    9  14 2
            17   10  15 1
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   18  23 1
            27   21  24 1
            28   24  25 1
            29   25  26 1
            30   13  27 1
///
